FDA encourages continued submission of reports related to seizures following e-cigarette use as part of agency’s ongoing scientific investigation of potential safety issue

FDA In Brief: FDA encourages continued submission of reports related to seizures following e-cigarette use as part of agency’s ongoing scientific investigation of potential safety issue

The U.S. Food and Drug Administration provided an update today on its ongoing scientific investigation of a potential safety issue related to seizures reported following e-cigarette use and is continuing to encourage the public to submit new or follow-up reports on this topic as requested in the agency’s announcement in April. The FDA has posted additional reports the agency has received since April related to e-cigarette users experiencing seizures. These additional reports of events that occurred over the last 10 years do not necessarily indicate an increase in frequency or prevalence of such incidents. In addition, some users reported other serious neurological symptoms such as fainting or tremors, which may or may not be related to seizures. In total, including those posted in April, the agency has received 127 reports of seizure or other neurological symptoms that occurred between 2010 and 2019. As part of its commitment to ...

Read More